 |
|
Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
Mahesh Kate, Robert Wannamaker, Harsha Kamble, Parnian Riaz, Laura C. Gioia, Brian Buck, Thomas Jeerakathil, Penelope Smyth, Ashfaq Shuaib, Derek Emery, Kenneth Butcher
J Stroke. 2018;20(1):122-130. Published online 2018 Jan 31 DOI: https://doi.org/10.5853/jos.2017.00178
|
|
Citations to this article as recorded by
 Time window and “tissue window”: two approaches to assist decision-making in strokes
XuYing Xiang, Fei Cao
Journal of Neurology.2019; 266(2): 283. CrossRef Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia
Sathyasivam Kaviarasi, Eiji Yuba, Atsushi Harada, Uma Maheswari Krishnan
Journal of Controlled Release.2019; 300: 22. CrossRef Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials
Shelagh B Coutts, Eivind Berge, Bruce CV Campbell, Keith W Muir, Mark W Parsons
International Journal of Stroke.2018; 13(9): 885. CrossRef Tenacity of Collateral Perfusion in Proximal Cerebral Arterial Occlusions 6–12 h after Onset
Beom Joon Kim, Hyeran Kim, Han-Gil Jeong, Mi Hwa Yang, Cheol Kyu Jung, Moon-Ku Han, Jae Hyoung Kim, Andrew M. Demchuk, Hee-Joon Bae
Cerebrovascular Diseases.2018; 45(5-6): 263. CrossRef
|